Jubilant Pharmova Ltd (BOM:530019)
₹ 1236.95 -19.4 (-1.54%) Market Cap: 195.93 Bil Enterprise Value: 213.85 Bil PE Ratio: 33.14 PB Ratio: 3.30 GF Score: 76/100

Q3 2020 Jubilant Life Sciences Ltd Earnings Call Transcript

Jan 31, 2020 / 11:30AM GMT
Release Date Price: ₹435.44 (-3.55%)
Operator

Ladies and gentlemen, good day, and welcome to Jubilant Life Sciences Limited Q3 and 9-month FY '20 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations. Thank you, and over to you, sir.

Ravi Agrawal
Jubilant Life Sciences Limited - Head of IR

Thank you. Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q3 and 9 months FY '20 earnings conference call.

I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.

On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. R. Sankaraiah, Executive Director of Finance; Mr. Alok Vaish, CFO Designate; Mr. Pramod Yadav, CEO, Jubilant Pharma; and Mr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot